GA-FARM-TO-PLATE
28.2.2023 21:34:42 CET | Business Wire | Press release
Today, Farm to Plate announced the immediate availability of Farm To Plate (F2P), a pioneering blockchain-based provenance and tracking product for the Food supply chain that will expand the scope of data transparency to the grassroots of the food industry – end-to-end, from the producers to the consumers. The Farm to Plate platform addresses increased regulatory demands for digitization and transparency through GS1 and FDA FSMA Rule #204 compliance and heightens brand trust, financial stability, and reputation by enabling a focus on sustainability, responsible farming, consumer transparency, and significantly reduced recall risk and size. See how it works.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006317/en/
Key Features and Benefits of Farm to Plate
- Microtipping: Enables direct tips to producers from end consumers that are securely, instantaneously transmitted over the blockchain, eliminating middlemen and chances of fraud while giving producers a great boost to their meager revenues.
- Immutable, end-to-end tracking and trace: Immutable, decentralized information ensures no single stakeholder has disproportionate information ownership, eliminating the risk of data fudging.
- Secure access control for information on the blockchain: Strong access controls enable granular control over who has access to what data, ensuring only relevant, required information is accessible to different parties.
- Built on GS1 standards and compliant with FDA FSMA Rule #204.
Fulfilling Consumers’ Need for End-to-end Transparency
In a globalized food supply chain where food is sourced and transported across continents, the level of transparency, from sourcing, transportation, to storage and other details, that consumers are now demanding is unprecedented. Research also proves that 73% of consumers prefer brands that are sustainable, honest, and transparent about how and where products were raised or grown. Sustainable production is also high on their wishlist, with them being willing to pay a huge premium - anywhere from 30% to 40% on average – for sustainably produced goods. “Farm to Plate will be revolutionary for food brands looking to develop a strong identity with the sustainability-focused modern consumer. By enabling transparency and the ability to directly connect to their suppliers, brands can project a strong image as a modern, conscious corporation to their customers. This is the beginning of a long journey of trust between consumers and food brands.”- Mika Liss, Strategic Advisor, Farm To Plate.
Farm to Plate Fills the Missing Links in the Supply Chain
Food brands are struggling with the weight of regulatory requirements and the consumers’ transparency demands. Providing such in-depth and reliable information in a complex global supply chain poses challenges. There is heavy dependency on manual processes making data vulnerable to fraud and preventing timely information from passing to all stakeholders. Farm to Plate uses permissioned blockchain, AI-driven tools, and automation through IoT devices to provide access-controlled, immutable, real-time data to the right stakeholders. “We’ve built F2P with open, industry-standard technology that integrates seamlessly with your existing systems. And the best part about it is, it’s modular, allowing us to extend its capabilities almost infinitely as we build out features in future releases.”- Saptarshi Choudhury, VP of Product at Farm To Plate.
Connecting Consumers and Farmers for Sustainable Ecosystems
Through innovative use of popular messaging platforms such as WhatsApp, voice transcription, vernacular language translations and offline functionality, Farm To Plate is the first track and trace solution truly accessible to the fisherman and farmer. Through microtipping, Farm to Plate will leverage the consumer-farmer connection to bring financial stability to the producer community and reduce the risk of overfarming.
“Farm To Plate is the first food supply chain solution that will connect every stakeholder to the other, and make them part of the system. Uniquely, we connect consumers and farmers directly - enabling consumer food trust through transparency and financial sustainability for producers through a single QR code. Our value proposition is enshrined in the 5 Ts: Trace, Track, Trade, Tip, Trust – and Tip is our favorite because it acknowledges the farmer.”- Pramod Sajja, President and CEO, Farm to Plate LLC. & Paramount Software Solutions Inc.
About Farm to Plate
The vision of the Blockchain team of Farm to Plate was to develop a product to transform the way the food and beverage industry operates. The success stories of Hyperledger Fabric resulted in its adoption to enable bringing the open-source ecosystem to the forefront of this technology. Farm to Plate wanted to build something that made a difference, and yet simple to adapt to fill the gaps in the existing food supply chain systems.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006317/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
